The effect of switching protease inhibitors to raltegravir on endothelial function, in HIV-infected patients

Krikke, M; Tesselaar, K; van den Berk, GEL; Otto, SA; Freriks, LH; van Lelyveld, SFL; Visseren, FJL; Hoepelman, AIM; Arends, JE

Krikke, M (reprint author), Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, Huispostnummer F02-126,POB 85500, NL-3508 GA Utrecht, Netherlands.

HIV CLINICAL TRIALS, 2018; 19 (2): 75

Abstract

Objective: Lipid management is one of the cornerstones of cardiovascular risk reduction. Treatment of HIV infection with protease inhibitors (PIs) may......

Full Text Link